SG-MY MedTech Corridor: Pure Global on Unlocking the New Fast-Track Approval Secret. cover art

SG-MY MedTech Corridor: Pure Global on Unlocking the New Fast-Track Approval Secret.

SG-MY MedTech Corridor: Pure Global on Unlocking the New Fast-Track Approval Secret.

Listen for free

View show details

About this listen

This week, we dive into a game-changing regulatory shift in Southeast Asia. Singapore's HSA and Malaysia's MDA have just formalized a fast-track approval pathway, allowing medical devices approved in one country to gain rapid access to the other. This episode breaks down what the new "Verification Route" is and how it impacts market entry strategy for MedTech companies. We explore how this reliance program transforms the business case for ASEAN expansion. For a company with a newly HSA-approved AI diagnostic tool, the daunting prospect of another 18-month review for Malaysia is now a thing of the past. This episode reveals how they can leverage their existing approval to slash timelines and costs, turning a major hurdle into a strategic advantage. In this episode, you will learn: - What is the Singapore-Malaysia medical device regulatory reliance program? - How does the "Verification Route" specifically reduce your time-to-market? - Which device classes are eligible for this new fast-track pathway? - Why is this a pivotal first step towards a single ASEAN regulatory system? - How can you update your 2026 expansion strategy to capitalize on this change? - What documentation from your HSA approval is key for the Malaysian submission? - Could this model be replicated with other countries like Thailand or Indonesia soon? Pure Global offers end-to-end regulatory consulting to streamline global market access for MedTech and IVD companies. We combine local expertise with advanced AI and data tools to turn regulatory complexity into a competitive advantage. To learn how we can help you navigate this new ASEAN landscape, contact us at info@pureglobal.com or visit https://pureglobal.com/.
No reviews yet